You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 7, 2024

CLINICAL TRIALS PROFILE FOR ORETIC


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for ORETIC

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00797862 ↗ Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for Hypertension Completed Novartis Phase 3 2008-11-01 This study will compare the safety and efficacy of initial combination treatment with aliskiren + amlodipine to sequential add-on treatment strategies with aliskiren or amlodipine in patients with hypertension.
NCT01258764 ↗ Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and Lisinopril Completed Scripps Translational Science Institute N/A 2010-11-01 The purpose of this trial is to evaluate if an objective clinical decision of anti-hypertensive therapy can be made using an N-of-1 (single patient) trial design.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ORETIC

Condition Name

Condition Name for ORETIC
Intervention Trials
Hypertension 2
Hypertension Treatment 1
Hypertension, Grade 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ORETIC
Intervention Trials
Hypertension 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ORETIC

Trials by Country

Trials by Country for ORETIC
Location Trials
Costa Rica 1
Greece 1
Switzerland 1
United States 1
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for ORETIC
Location Trials
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ORETIC

Clinical Trial Phase

Clinical Trial Phase for ORETIC
Clinical Trial Phase Trials
Phase 3 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ORETIC
Clinical Trial Phase Trials
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ORETIC

Sponsor Name

Sponsor Name for ORETIC
Sponsor Trials
Novartis 1
Scripps Translational Science Institute 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ORETIC
Sponsor Trials
Industry 1
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.